These results may provide the basis for new therapeutic strategies that would involve the ex vivo pharmacological treatment of melanoma cells with IFN-γ and GGTI-298 to produce useful cells for vaccination or adoptive transfer therapies. This evidence concerns the gene PGGT1B and melanoma.